Anavex Life Sciences Corp (AVXL)
4.05
-0.15
(-3.57%)
USD |
NASDAQ |
Jun 25, 16:00
4.05
0.00 (0.00%)
After-Hours: 20:00
Anavex Life Sciences Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
September 30, 2014 | -0.0007M |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | -0.0023M |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
March 31, 2011 | 0.00 |
December 31, 2010 | 0.00 |
September 30, 2010 | -0.0033M |
June 30, 2010 | 0.00 |
March 31, 2010 | 0.00 |
December 31, 2009 | 0.00 |
Date | Value |
---|---|
September 30, 2009 | |
June 30, 2009 | |
March 31, 2009 | |
December 31, 2008 | |
September 30, 2008 | 0.1046M |
June 30, 2008 | -0.0269M |
March 31, 2008 | -0.0788M |
December 31, 2007 | 0.00 |
September 30, 2007 | 0.00 |
June 30, 2007 | 0.00 |
March 31, 2007 | 0.00 |
December 31, 2006 | 0.00 |
September 30, 2006 | 0.00 |
June 30, 2006 | 0.00 |
March 31, 2006 | 0.00 |
December 31, 2005 | 0.00 |
September 30, 2005 | 0.00 |
June 30, 2005 | 0.00 |
March 31, 2005 | 0.00 |
December 31, 2004 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
Ventyx Biosciences Inc | 41.76M |
Checkpoint Therapeutics Inc | -- |
Biogen Inc | -66.00M |
Amicus Therapeutics Inc | 7.537M |
InfuSystems Holdings Inc | -0.418M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -11.66M |
Cash from Financing (Quarterly) | 7.277M |
Free Cash Flow | -32.48M |
Free Cash Flow Per Share (Quarterly) | -0.1413 |
Free Cash Flow Yield | -9.80% |